It has been demonstrated that transcriptionally active genes in gliomas such as calmodulin (CALM1) are characterized by active histone marks, whereas transcriptionally silent genes, such as keratin 72 (KRT72), display repressive histone modifications [53]. The gene discussed is KRT72; the disease is glioma.